Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
BACKGROUND Vitiligo is a common, often distressing condition. Many of the patients do not
achieve sufficient effect from what is regarded as the treatment of choice at present, narrow
band(NB)UVB(Tl01). There are reports on some patients partly successfully treated with
Tacrolimus ointment.
AIM OF THE STUDY We want to study whether Tacrolimus ointment may give an additive effect on
symmetric vitiligo in combination with NB-UVB.
METHODS This is a double blind left/right comparative study with 6 months treatment time.
Patients are treated with whole body NB-UVB x 2 or x 3 weekly, in addition to Tacrolimus
ointment versus placebo every night on affected half body sites. To measure effects we use
photodocumentation in addition to morphometric registration of symmetric target lesions every
6 weeks.